• Products
    • VitaSmart™ Hypothermic Oxygenated Perfusion System
    • Belzer UW® Cold Storage Solution
    • Belzer MPS® UW Machine Perfusion Solution
    • EasiSlush® Sodium Chloride Solution
    • Cannulas for Organ Perfusion
    • International Availability
  • About
    • About Bridge to Life Ltd.
    • Company Leadership
    • News & Press Releases
    • Events
    • Scientific Advisory Board
    • Bridge to HOPE
    • Webinars
  • Clinical Resource Library
  • Contact & Support
    • Contact Us
    • Customer Feedback Form
    • Coordinated Vulnerability Disclosure Process
Trusted Solutions. Advanced Technology. Uncompromising Quality.
  • Products
    • VitaSmart™ Hypothermic Oxygenated Perfusion System
    • Belzer UW® Cold Storage Solution
    • Belzer MPS® UW Machine Perfusion Solution
    • EasiSlush® Sodium Chloride Solution
    • Cannulas for Organ Perfusion
    • International Availability
  • About
    • About Bridge to Life Ltd.
    • Company Leadership
    • News & Press Releases
    • Events
    • Scientific Advisory Board
    • Bridge to HOPE
    • Webinars
  • Clinical Resource Library
  • Contact & Support
    • Contact Us
    • Customer Feedback Form
    • Coordinated Vulnerability Disclosure Process

DCD

DCD

Evidence-Based Recommendations for the Use of Machine Perfusion in Kidney Transplantation

Machine perfusion is becoming essential in Indian kidney transplantation as reliance on marginal donors (ECD, DCD) grows. This expert consensus, developed with NOTTO, recommends HMP for all DCD [...]

Read More
Pushing the Limit for Marginal Grafts in the Era of Machine Perfusion: A Tale of HOPE From a Leading Italian Institution

Pushing the Limit for Marginal Grafts in the Era of Machine Perfusion: A Tale of HOPE From a Leading Italian Institution

Read More
Economic Assessment Of Hypothermic Oxygenated Machine Perfusion In Liver Transplantation: Interim Analysis, D. Axelrod, University of Iowa, Iowa City, IA et al.

Economic Assessment Of Hypothermic Oxygenated Machine Perfusion In Liver Transplantation: Interim Analysis, D. Axelrod, University of Iowa, Iowa City, IA et al.

This abstract presents an economic assessment of hypothermic oxygenated perfusion (HOPE) for liver transplantation in the US, using interim data from a randomized trial, Bridge to HOPE, comparing [...]

Read More
Success Of Ex Situ End Ischemic Hypothermic Oxygenated Perfusion (hope) Prior To Liver Transplantation – The Bridge To Hope Pivotal Multicenter Randomized Controlled Clinical Trial On The Safety And Effectiveness Of The VitaSmart Liver Machine Perfusion System

Success Of Ex Situ End Ischemic Hypothermic Oxygenated Perfusion (hope) Prior To Liver Transplantation – The Bridge To Hope Pivotal Multicenter Randomized Controlled Clinical Trial On The Safety And Effectiveness Of The VitaSmart Liver Machine Perfusion System

The Bridge to HOPE trial is a pivotal multicenter randomized controlled study in the US comparing HOPE via the VitaSmart liver machine to standard static cold storage (SCS) for extended […]

Read More
Decreased Ischemic Cholangiopathy With Hypothermic Oxygenated Perfusion: Sub Analysis Of Biliary Outcomes From The Us Pivotal Multicenter Trial Of The Vitasmart For Hope In Liver Transplantation

Decreased Ischemic Cholangiopathy With Hypothermic Oxygenated Perfusion: Sub Analysis Of Biliary Outcomes From The Us Pivotal Multicenter Trial Of The Vitasmart For Hope In Liver Transplantation

Detailed analysis of DCD biliary outcomes in the multicenter randomized controlled trial (Bridge to HOPE) that evaluated hypothermic oxygenated perfusion (HOPE) versus static cold storage (SCS) [...]

Read More
Histidine–Tryptophan–Ketoglutarate (HTK) Is Associated with Reduced Graft Survival in Deceased Donor Livers, Especially Those Donated After Cardiac Death

Histidine–Tryptophan–Ketoglutarate (HTK) Is Associated with Reduced Graft Survival in Deceased Donor Livers, Especially Those Donated After Cardiac Death

Registry-based analysis demonstrating reduced graft survival associated with HTK in deceased donor liver transplantation, with the strongest signal in DCD livers. This publication is commonly [...]

Read More
Early Allograft Dysfunction As A Clinical Trial Primary Outcome Measure Correlates With Later Outcomes; Analysis From A US Pivotal Multicenter Medical Device Trial Of Hypothermic Oxygenated Perfusion For Liver Transplant

Early Allograft Dysfunction As A Clinical Trial Primary Outcome Measure Correlates With Later Outcomes; Analysis From A US Pivotal Multicenter Medical Device Trial Of Hypothermic Oxygenated Perfusion For Liver Transplant

This abstract presents results from a U.S. pivotal multicenter RCT evaluating early allograft dysfunction (EAD) as a primary outcome in liver transplant clinical trials, using data from the [...]

Read More
Economic Benefit of Hypothermic Liver Perfusion

Economic Benefit of Hypothermic Liver Perfusion

This poster presents a financial assessment of hypothermic oxygenated perfusion (HOPE) in liver transplantation, using data from a U.S. randomized clinical trial comparing HOPE after static cold [...]

Read More

Hypothermic oxygenated perfusion (HOPE): Results of our experience in the first 31 liver transplants

This poster from Dora Gómez Pasantes and colleagues at A Coruña University Hospital describes their experience using hypothermic oxygenated perfusion (HOPE) via the VitaSmart with 31 cadaveric [...]

Read More

Latest Posts

UK NICE Issues Guidance Recommending Routine NHS Funding for Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion System

UK NICE Issues Guidance Recommending Routine NHS Funding for Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion System

August 27, 2026

DULUTH, GA, & LONDON, UK - August 27, 2026 - Bridge to Life™ Ltd., a global leader in organ preservation solutions and perfusion technologies, today highlighted the recent release of […]

Read more
Bridge to Life Raises $110 Million to Make Hypothermic Oxygenated Perfusion the Standard of Care in Liver Transplantation and Beyond

Bridge to Life Raises $110 Million to Make Hypothermic Oxygenated Perfusion the Standard of Care in Liver Transplantation and Beyond

August 12, 2026

Financing will further accelerate the already successful early commercial rollout of VitaSmart™ HOPE System Company also advancing an active organ viability assessment tool designed to raise industry standards with a […]

Read more
New Investigator Initiated Research Data Demonstrate Efficacy and Safety of the Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System in Multiple Organ Transplants

New Investigator Initiated Research Data Demonstrate Efficacy and Safety of the Bridge to Life’s VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System in Multiple Organ Transplants

June 23, 2026

Studies in human uterus and small intestine transplants, including head-to-head comparison with normothermic oxygenated perfusion, presented at 2026 Annual Meeting of the American Transplant Congress (ATC) in Boston Duluth, GA […]

Read more




full

info@b2ll.com

US Operations:
3300 Breckinridge Blvd. Suite 200 | Duluth, GA 30096 USA

© 2026 Bridge to Life™ Ltd. All rights reserved.

EVENTS



Sep


15


September 15 – September 16


National Critical Issues Forum



Sep


16


September 16 – September 17


XIII International Course on HPB surgery



Sep


16


September 16 – September 18


SFPC


View Calendar


EXPLORE BTL

Products

Contact & Support

About

Recent News

Privacy Policy

Social Responsibility

Certifications

JOIN OUR EMAIL LIST

SOCIAL MEDIA

Linkedin

X

VitaSmart™ is available in Europe, Saudi Arabia, India, and in all countries accepting the CE mark. VitaSmart™ Hypothermic Oxygenated Perfusion System is authorized to be sold in the US market, pending regulatory approval in all other countries.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search